Suvorexant and Sleep/Delirium in ICU Patients
Conditions: Insomnia; Sleep Fragmentation; Sleep Initiation and Maintenance Disorders; Postoperative Delirium Interventions: Drug: Suvorexant 20 mg; Drug: Placebo oral tablet Sponsors: Beth Israel Deaconess Medical Center; Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials